SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-028610
Filing Date
2024-03-08
Accepted
2024-03-08 16:00:30
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K glto-20231231.htm   iXBRL 10-K 2425898
2 EX-4.2 glto-ex4_2.htm EX-4.2 32811
3 EX-10.2 glto-ex10_2.htm EX-10.2 662536
4 EX-21.1 glto-ex21_1.htm EX-21.1 7782
5 EX-23.1 glto-ex23_1.htm EX-23.1 6627
6 EX-31.1 glto-ex31_1.htm EX-31.1 16630
7 EX-31.2 glto-ex31_2.htm EX-31.2 16627
8 EX-32.1 glto-ex32_1.htm EX-32.1 14158
9 EX-97 glto-ex97.htm EX-97 35779
10 GRAPHIC img109565643_0.jpg GRAPHIC 46287
11 GRAPHIC img109565643_1.jpg GRAPHIC 51807
12 GRAPHIC img109565643_2.jpg GRAPHIC 188521
  Complete submission text file 0000950170-24-028610.txt   9627082

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT glto-20231231.xsd EX-101.SCH 1004563
89 EXTRACTED XBRL INSTANCE DOCUMENT glto-20231231_htm.xml XML 1188954
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39655 | Film No.: 24734190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)